Clinical Trials Search Results

Results 1-10 of 375 for your search
Show Search Criteria
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 859 locations
Nivolumab after Combined Modality Therapy in Treating Patients with High Risk Stage II-IIIB Anal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 677 locations
Brentuximab Vedotin and Nivolumab with or without Ipilimumab in Treating Patients with Relapsed or Refractory Hodgkin Lymphoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 367 locations
Nivolumab in Treating Patients with Localized Kidney Cancer Undergoing Nephrectomy
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 289 locations
1 2 3 ... 38 Next >